Lisa Schechner is a biotechnology investor at Commodore Capital. Prior to joining Commodore, Lisa worked on the Investments Team at Roivant Sciences, a biopharmaceutical company with a mission to develop transformative medicines. At Roivant, Lisa focused on identifying, evaluating, licensing and acquiring promising therapeutic development candidates. Prior to Roivant, Lisa was a management consultant at Bain & Company, working with clients across industries including pharmaceuticals, financial services and non-profits. Lisa earned her AB in Molecular and Cellular Biology from Harvard University, where she was a Harvard College Scholar.

Lisa grew up in Long Island, New York, enjoys exploring the city, and has recently taken up running and hiking.